MDx/CDx Focus: BRL Launches IHPV mRNA Test; BrevaGen Adoption Continues in Texas | GenomeWeb

BRL launches InCellDx's HPV mRNA Test

Bio-Reference Laboratories announced this week that its GenPath Women's Health division has launched a new test called GenCerv.

The test is based on InCellDx's patented and proprietary HPV mRNA quantification technology. GenCerv will quantify E6 and E7 oncogene overexpression in distinct cell types, which, according to BRL, will help doctors diagnose HPV and identify patients whose disease will not progress to cervical cancer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.